Pure Science News: All the science news you can handle in a single feed

	Pure Science All the science news you can handle in a single feed

The aging scientific workforce collides with rising fabricating citations in medical journals

Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Sign up here. The AC broke in STAT’s NYC bureau, so I guess summer has arrived. Happy Friday. Read the rest…

May 08, 2026

Opinion: We need more men in nursing

While the number of Americans in need of care keeps rising, many health systems are struggling to find qualified nurses. The demand for qualified nurses is projected to increase nationwide, with nearly 200,000 annual job openings expected....

May 08, 2026

Why we left the FDA: Six former officials share their stories

A year after U.S. DOGE Service cuts shook up the federal government, STAT’s FDA reporter Lizzy Lawrence has been speaking with former officials about their time at the agency. Two weeks ago, I hit the road with Lizzy to interview six of...

May 08, 2026

Opinion: STAT+: Medicare’s new RAPID pathway is a breakthrough for adults. Children are still waiting

In late April, the Centers for Medicare and Medicaid Services and the Food and Drug Administration announced the Regulatory Alignment for Predictable and Immediate Device, or RAPID, coverage pathway. On paper, it is exactly what the...

May 08, 2026

Fraudulent citations, blamed on AI hallucinations, are becoming more common in research papers

Citations in academic papers are intended to ground research in the work that preceded it, over time creating something of a family tree explaining the roots of ideas, protocols, and studies. But a growing number of these citations...

May 07, 2026

Key takeaways from WHO briefing on hantavirus cruise ship outbreak

The MV Hondius, the cruise ship that has garnered global attention because of an apparent outbreak of person-to-person spread hantavirus infections, is on the move. At the request of Tedros Adhanom Ghebreyesus, the World Health...

May 07, 2026

Science is becoming less disruptive. Is an aging workforce to blame?

Physicist Albert Einstein, widely regarded as one of the most prolific scientists of the past century, conducted much of his transformative work at the beginning of his career, before spending years defending his theories against the...

May 07, 2026

Seaport’s IPO adventure, obesity pill battles, and Makary’s troubles

On this week’s episode of “The Readout LOUD,” we chat with Seaport Therapeutics CEO Daphne Zohar, fresh off the biotech’s successful IPO. Plus, Elaine, Allison, and Adam chat about this week’s notable news, including the obesity pill...

May 07, 2026

Official leading CDC’s cruise ship program retires

WASHINGTON — The top U.S. official responsible for public health on cruise ships is stepping down, according to an internal Centers for Disease Control and Prevention announcement obtained by STAT. The retirement of Luis Rodríguez, who has...

May 07, 2026

STAT+: Pharmalittle: We’re reading about Sanofi and an FDA voucher, FDA rethinking a rejection, and more

Top of the morning to you, and a fine one it is. Sunny skies and mild breezes are enveloping the Pharmalot campus once again. And to celebrate, we are brewing still more cups of stimulation and inviting you to join us. Our choice today is...

May 07, 2026

STAT+: More political interference at the FDA?

You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and policy of health and medicine. Sign up here to receive it in your inbox on Tuesdays and Thursdays. This is a photo of a young...

May 07, 2026

STAT+: OpenAI’s health policy wishlist, CGM news from Dexcom, and more

You’re reading the web edition of STAT’s Health Tech newsletter, our guide to how technology is transforming the life sciences. Sign up to get it delivered in your inbox every Tuesday and Thursday. Good morning health tech...

May 07, 2026

STAT+: FDA to reconsider treatment for rare cancer after surprise rejection

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. The Trump administration is touting massive projected savings from its still-secret drug pricing deals,...

May 07, 2026

Opinion: Eugene Braunwald, ‘father of modern cardiology,’ told me he had two dreams. One came true

Eugene Braunwald, who was widely recognized as “The Father of Modern Cardiology,” died on April 22 at the age of 96. When I first learned about his death, I thought about our many conversations — particularly the two major visions he told...

May 07, 2026

STAT+: What was lost at the FDA

WASHINGTON — After defending the Trump administration’s dramatic health cuts as a solution to bureaucratic bloat, the health department’s leaders are beginning to realize that a demoralized, diminished workforce will not help them achieve...

May 07, 2026

Cruise ship hantavirus outbreak worries experts, though they discount pandemic fears

The outbreak of hantavirus on a cruise ship moored off the western coast of Africa is gripping a world primed by recent painful experience to be on edge for the next Covid-19-like event. It’s no wonder: People trapped on a ship where a...

May 07, 2026

STAT+: Color me skeptical: Drinking gold is not an ALS cure

This is the online version of Adam’s Biotech Scorecard, a subscriber-only newsletter. STAT+ subscribers can sign up here to get it delivered to their inbox. It’s been a while since I wrote a “Mean Adam” newsletter. The biotech...

May 07, 2026

Hospital shootings steadily increased since 2000

Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Sign up here. Good morning. I was charmed by this profile of tween life in America, both as a former tween girl and as a reporter. I...

May 07, 2026

STAT+: Next-gen Duchenne drug from Entrada disappoints

Entrada Therapeutics’ next-generation drug for Duchenne muscular dystrophy disappointed in an early trial, raising questions about the company’s competitiveness in an increasingly crowded field. Entrada is one of a group of companies...

May 07, 2026

STAT+: FDA to reconsider treatment for rare cancer after its surprise rejection

Two companies developing a therapy for a rare blood cancer have reached an agreement with the Food and Drug Administration that walked back the agency’s main reason for rejecting the drug in January. Pierre Fabre Pharmaceuticals and...

May 07, 2026

STAT+: Oregon hospitals won’t outsource to national physician chain after all

After a tidal wave of blowback that culminated in a lawsuit, a nonprofit health system has reversed course in its plan to replace its Oregon emergency physicians with a national chain. PeaceHealth’s announcement Wednesday didn’t...

May 07, 2026

Trump administration’s drug strategy is at odds with recent actions on funding, policy

The White House’s new strategy for addressing the nation’s drug crisis calls for a number of consensus public health measures: the overdose-reversal medication naloxone, medication-assisted treatment, and test strips used to detect...

May 07, 2026

STAT+: Administration report on most favored nation drug pricing raises new details — and questions

WASHINGTON — The Trump administration on Tuesday released the most detailed look to date at its drug pricing policy and its purported impact, claiming huge future savings from the program. The report, from the administration’s own Council...

May 06, 2026

STAT+: Sanofi asks to pull diabetes drug out of FDA voucher program after political appointee interfered with review

WASHINGTON — Sanofi has asked the Food and Drug Administration to pull its type 1 diabetes drug, teplizumab, out of Commissioner Marty Makary’s new speedy drug review program. The move comes after acting Center for Drug Evaluation...

May 06, 2026

STAT+: Color Health moving deeper into cancer services, complete with virtual ‘tumor boards’

The way Color Health’s CEO Othman Laraki sees it, cancer has a scaling problem. New science regularly sets new standards of care, increasing the intricacy of managing an already complex illness. Cancer patients are multiplying faster than...

May 06, 2026

Why the FDA is authorizing fruit-flavored vapes

WASHINGTON — The Food and Drug Administration authorized fruit-flavored vapes for the first time on Tuesday, after reports of pressure from President Trump. The approval might sound like a move guaranteed to alarm public health...

May 06, 2026

STAT+: How a global effort to explore the ‘dark proteome’ is upending our understanding of human disease

In 2019, Sebastiaan van Heesch was trying to pry apart the secrets of a broken heart. A systems biologist, van Heesch used a newish method to analyze the contents of ribosomes, cellular protein factories, in a collection of frozen hearts...

May 06, 2026

STAT+: When the path to good AI is littered with bad data

You’re reading the web edition of STAT’s AI Prognosis newsletter, our subscriber-exclusive guide to artificial intelligence in health care and medicine. Sign up to get it delivered in your inbox every Wednesday. I’m stoked...

May 06, 2026

STAT+: Novo Nordisk’s less-bad news on its Wegovy pill boosts earnings and share price

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Good morning. We’ve got more earnings today, and my colleague Drew Joseph brings us a dispatch from Rome....

May 06, 2026

STAT+: Pharmalittle: We’re reading about a PhRMA ad campaign aimed at 340B, sales of Novo’s obesity pill, and more

Good morning, everyone, the middle of the week has arrived, and this calls for a celebratory cup or two of stimulation. How so? Well, you made it this far, which can be an accomplishment, after all. Moreover, there is always good reason to...

May 06, 2026

HHS tackles ‘overmedication’

Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Sign up here. Good morning. Are you keeping up with “The Odyssey”? I’m right on track, six books in. Athena’s working hard for her...

May 06, 2026

Opinion: Trump’s executive order on psychedelics is the right move. But is my field ready for it?

I have spent the last 10 years of my life investigating psychedelics as novel treatments for mental health conditions. When President Trump signed his executive order on psychedelic medicines, my first thought was: He got this one right....

May 06, 2026